| Name | Title | Contact Details |
|---|
It is hard to believe that 17 years ago, Jim and Kathy Coover founded Isagenix in partnership with John Anderson and six employees in a small office in Tempe, AZ. Today, we are the largest company by revenue headquartered in Gilbert, AZ, and the 4th largest for-profit company in AZ. We continue to gain recognition and respect for our strong business practices both nationally and internationally. Our honors have included the Better Business Bureau naming us a 2018 BBB Torch Awards for Ethics Finalist in recognition of our commitment to “do the right thing.” In addition, Jim Coover was named 2017 CEO of the Year, and in 2018 and 2019 we were named one of the Best Places to Work, one of the Healthiest Employers, and one of the Valley`s 10 Largest Corporate Philanthropists. Today our family-owned and operated business is in 14 markets, has half a million customers worldwide, and offers more than 100 life-changing products, packs, and systems!
Fonemed provides virtual nurse triage and software solutions to increase access to quality healthcare and control costs. Fonemed was founded in 1996 by a group of physicians, philanthropists and businesspeople who recognized the need for improved healthcare worldwide and saw telephone-based triage as the premier method to provide that care.
Swanky Smiles started with just one question... What if orthodontics was designed around YOU? We are a mobile orthodontic business specializing in the greatest orthodontic technology in the world. Invisalign. While you get to enjoy our crazy convenient services of not only coming to you for all of your appointments, and being open 7 days a week for 12 hours a day.. You can relax knowing your orthodontic treatment receives all the same benefits, if not more, with Swanky Smiles. --- Swanky Smiles currently services 40+ cities in the U.S.
Atlas Medical Software is a Calabasas, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Versartis, Inc. (NASDAQ: VSAR) is an endocrine-focused biopharmaceutical company developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. The company is led by a management team with rich experience and expertise discovering, developing and commercializing innovative therapeutics for the life sciences industry. Versartis` mission is to develop, manufacture and commercialize novel therapeutics to improve and transform treatment for patients with orphan endocrine disorders. Versartis is well-positioned to deliver a major innovation to the global growth hormone deficiency (GHD) market with the company`s most advanced clinical candidate, somavaratan. Somavaratan is a novel, long-acting form of recombinant human growth hormone that is in global late-stage clinical trials to treat GHD in children and adults. Twice-monthly somavaratan is intended to reduce the burden of daily injection therapy by requiring significantly fewer injections, potentially improving compliance/adherence and treatment outcomes.